Skip to main content
. 2020 Aug 20;15(8):e0237868. doi: 10.1371/journal.pone.0237868

Table 2. Potentially inappropriate prescribing rates.

N Total person years of potentially inappropriate prescribing Total person years of follow up Potentially inappropriate prescribing rate per 100 person-years IRR (95% CI) IRR p value
Total cohort 25,016 72,453 57,707 125.6
Age (years)
    66-<80 14,490 43,534 34,576 125.9 Reference 0.35
    ≥80 10,526 28,919 23,131 125.0 0.99 (0.98, 1.01)
Sex
    Male 14,000 37,315 31,431 118.7 Reference <0.0001
    Female 11,016 35,138 26,276 133.7 1.13 (1.11, 1.14)
Index year
    2011 5,611 25,630 20,865 122.8 Reference
    2012 2,033 6,470 5,198 124.5 1.01 (0.99, 1.04) 0.34
    2013 3,737 11,344 8,835 128.4 1.05 (1.02, 1.07) <0.0001
    2014 4,786 12,516 9,997 125.2 1.02 (1.00, 1.04) 0.08
    2015 4,712 10,205 7,945 128.5 1.05 (1.02, 1.07) 0.0001
    2016 3,387 5,425 4,206 129.0 1.05 (1.02, 1.08) 0.001
    2017 750 864 662 130.4 1.06 (0.99, 1.14) 0.08
Potentially inappropriate prescription categories
Medications of concern in CKD 25,016 12,156 57,707 21.1
Medications of concern in older patients 25,016 42,808 57,707 74.2
Medications to be avoided at an eGFR <15 mL/min/1.73 m2a 5,689 336 9,791 3.4
Medications dispensed above the recommended dose for an eGFR <30 mL/min/1.73 m2 25,016 47 57,707 0.1

aExamined in sub-group of patients with a baseline eGFR <15 mL/min/1.73 m2.

Abbreviations: CKD, chronic kidney disease, eGFR: estimated glomerular filtration rate, IRR: incidence rate ratio.